시장보고서
상품코드
1087402

세계의 시판약(OTC 의약품) 및 식이보충제 시장(2022-2026년)

Global Over the Counter (OTC) Drugs and Dietary Supplements Market 2022-2026

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 120 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 시판약(OTC 의약품) 및 식이보충제 시장 규모는 2022-2026년간 579억 6,000만 달러의 증가가 전망되며, 예측기간 중 5.44%의 CAGR로 성장할 것으로 예측됩니다.

다수의 결제 옵션, 제품 혁신, 유리한 규제 체계가 시장을 견인하고 있습니다.

세계의 시판약(OTC 의약품) 및 식이보충제(Over the Counter (OTC) Drugs and Dietary Supplements) 시장에 대해 조사 분석했으며, 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개사 벤더를 커버하는 벤더 분석을 제공합니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 상황

  • 시장 생태계

제3장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2021년)
  • 시장 전망 : 2021-2026년 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제5장 유통 채널별 시장 세분화

  • 시장 부문
  • 유통 채널별 비교
  • 온라인 : 시장 규모와 예측(2021-2026년)
  • 오프라인 : 시장 규모와 예측(2021-2026년)
  • 유통 채널별 시장 기회

제6장 고객 상황

  • 고객 상황 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2021-2026년)
  • 유럽 : 시장 규모와 예측(2021-2026년)
  • 아시아 : 시장 규모와 예측(2021-2026년)
  • 기타 지역(ROW) : 시장 규모와 예측(2021-2026년)
  • 미국 : 시장 규모와 예측(2021-2026년)
  • 독일 : 시장 규모와 예측(2021-2026년)
  • 중국 : 시장 규모와 예측(2021-2026년)
  • 캐나다 : 시장 규모와 예측(2021-2026년)
  • 인도 : 시장 규모와 예측(2021-2026년)
  • 지역 상황별 시장 기회

제8장 성장 촉진요인, 과제, 동향

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 상황

  • 개요
  • 벤더 상황
  • 혼란 상황
  • 업계 위험

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • Bayer AG
  • Colgate Palmolive Co.
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novartis AG
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • The Procter and Gamble Co.

제11장 부록

KSM 22.06.17

Technavio has been monitoring the over-the-counter drugs and dietary supplements market and it is poised to grow by $ 57.96 bn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period. Our report on the over-the-counter drugs and dietary supplements market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the availability of multiple payment options, product innovations, and favorable regulatory frameworks.

The over-the-counter drugs and dietary supplements market analysis includes distribution channel segment and geographic landscape.

Technavio's over the counter drugs and dietary supplements market is segmented as below:

By Distribution Channel

  • Online
  • Offline

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing geriatric population as one of the prime reasons driving the over-the-counter drugs and dietary supplements market growth during the next few years. Also, inclination of pharmaceutical companies toward OTC drugs from RX drugs and increasing awareness for vitamin supplements and weight loss products will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on over the counter drugs and dietary supplements market covers the following areas:

  • Over the counter drugs and dietary supplements market sizing
  • Over the counter drugs and dietary supplements market forecast
  • Over the counter drugs and dietary supplements market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading over the counter drugs and dietary supplements market vendors that include AbbVie Inc., Alfresa Holdings Corp., Alkalon AS, Alliance Pharma Plc, Bausch Health Companies Inc., Bayer AG, Colgate Palmolive Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Ltd., and The Procter and Gamble Co. Also, the over-the-counter drugs and dietary supplements market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Distribution Channel

  • 5.1 Market segments
  • Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
  • 5.2 Comparison by Distribution Channel
  • Exhibit 26: Chart on Comparison by Distribution Channel
  • Exhibit 27: Data Table on Comparison by Distribution Channel
  • 5.3 Online - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Online - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 29: Data Table on Online - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 30: Chart on Online - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Online - Year-over-year growth 2021-2026 (%)
  • 5.4 Offline - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Offline - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 33: Data Table on Offline - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 34: Chart on Offline - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Offline - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Distribution Channel
  • Exhibit 36: Market opportunity by Distribution Channel ($ billion)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 Canada - Market size and forecast 2021-2026
  • Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.11 India - Market size and forecast 2021-2026
  • Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 Bayer AG
  • Exhibit 85: Bayer AG - Overview
  • Exhibit 86: Bayer AG - Business segments
  • Exhibit 87: Bayer AG - Key offerings
  • Exhibit 88: Bayer AG - Segment focus
  • 10.4 Colgate Palmolive Co.
  • Exhibit 89: Colgate Palmolive Co. - Overview
  • Exhibit 90: Colgate Palmolive Co. - Business segments
  • Exhibit 91: Colgate Palmolive Co. - Key offerings
  • Exhibit 92: Colgate Palmolive Co. - Segment focus
  • 10.5 GlaxoSmithKline Plc
  • Exhibit 93: GlaxoSmithKline Plc - Overview
  • Exhibit 94: GlaxoSmithKline Plc - Business segments
  • Exhibit 95: GlaxoSmithKline Plc - Key news
  • Exhibit 96: GlaxoSmithKline Plc - Key offerings
  • Exhibit 97: GlaxoSmithKline Plc - Segment focus
  • 10.6 Johnson and Johnson
  • Exhibit 98: Johnson and Johnson - Overview
  • Exhibit 99: Johnson and Johnson - Business segments
  • Exhibit 100: Johnson and Johnson - Key news
  • Exhibit 101: Johnson and Johnson - Key offerings
  • Exhibit 102: Johnson and Johnson - Segment focus
  • 10.7 Novartis AG
  • Exhibit 103: Novartis AG - Overview
  • Exhibit 104: Novartis AG - Business segments
  • Exhibit 105: Novartis AG - Key offerings
  • Exhibit 106: Novartis AG - Segment focus
  • 10.8 Pfizer Inc.
  • Exhibit 107: Pfizer Inc. - Overview
  • Exhibit 108: Pfizer Inc. - Product / Service
  • Exhibit 109: Pfizer Inc. - Key news
  • Exhibit 110: Pfizer Inc. - Key offerings
  • 10.9 Reckitt Benckiser Group PLC
  • Exhibit 111: Reckitt Benckiser Group PLC - Overview
  • Exhibit 112: Reckitt Benckiser Group PLC - Business segments
  • Exhibit 113: Reckitt Benckiser Group PLC - Key offerings
  • Exhibit 114: Reckitt Benckiser Group PLC - Segment focus
  • 10.10 Sanofi
  • Exhibit 115: Sanofi - Overview
  • Exhibit 116: Sanofi - Business segments
  • Exhibit 117: Sanofi - Key news
  • Exhibit 118: Sanofi - Key offerings
  • Exhibit 119: Sanofi - Segment focus
  • 10.11 Sun Pharmaceutical Industries Ltd.
  • Exhibit 120: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 121: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 122: Sun Pharmaceutical Industries Ltd. - Key offerings
  • 10.12 The Procter and Gamble Co.
  • Exhibit 123: The Procter and Gamble Co. - Overview
  • Exhibit 124: The Procter and Gamble Co. - Business segments
  • Exhibit 125: The Procter and Gamble Co. - Key news
  • Exhibit 126: The Procter and Gamble Co. - Key offerings
  • Exhibit 127: The Procter and Gamble Co. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 128: Inclusions checklist
  • Exhibit 129: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 130: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 131: Research methodology
  • Exhibit 132: Validation techniques employed for market sizing
  • Exhibit 133: Information sources
  • 11.5 List of abbreviations
  • Exhibit 134: List of abbreviations
    • health: Includes veterinary drugs (excluded from the scope of the report)
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제